分形维数作为前列腺癌分级生物标志物的验证与诊断准确性
本研究在153例经活检证实的前列腺癌患者中,利用多扫描仪来源的临床DCE-MRI数据回顾性计算病灶边缘的分形维数(FD),评估其作为国际泌尿病理学会分级分组(ISUP-GG)定量生物标志物的价值。FD可作为前列腺癌无创分级生物标志物,且适用于不同MRI扫描仪和脂肪饱和方案。
要点
- FD阈值2.31可区分ISUP-GG1-2与3-5,敏感度95.2%,特异度92.9%。
- FD与ISUP-GG分级显著相关(R=0.87),各级FD均值从2.17递增至2.42。
- 不同扫描仪间需以闭孔内肌为参考进行信号强度标准化后FD才具可比性。
核心结论
- FD是基于标准临床DCE-MRI的前列腺癌分级准确生物标志物,可无创区分ISUP-GG1-2与3-5。
- FD测量在不同MRI扫描仪和脂肪饱和方案间具有良好的通用性和可重复性。
研究设计与样本
- 回顾性研究,纳入153例经活检证实的前列腺癌患者,年龄48.6-83岁(均值67.0±7.1岁)。
- ISUP-GG分布:1级n=2,2级n=68,3级n=44,4级n=21,5级n=18。
- 影像来源于多台扫描仪,采用不同脂肪饱和方案,FD从DCE-MRI病灶边缘回顾性计算。
- 以闭孔内肌为参考进行信号强度(SI)标准化,20例由独立观察者重复提取FD以评估可重复性。
关键影像表现/征象
- ISUP-GG各级FD均值:GG1为2.17±0.01,GG2为2.26±0.04,GG3为2.34±0.04,GG4为2.41±0.03,GG5为2.42±0.04。
- 图像标准化后,不同扫描仪间肿瘤信号强度分布相似。
- 20例重复测量中,观察者间FD平均差为-0.01,Bland-Altman一致性界限为-0.08至+0.05。
诊断标准与关键数值
- 预定义阈值2.31区分ISUP-GG1-2与3-5:敏感度95.2%,特异度92.9%,诊断准确性94.1%。
- FD可重复性:20例中观察者间平均差-0.01,一致性界限-0.08至+0.05。
临床应用与阅片要点
- FD阈值2.31可用于DCE-MRI上区分低级别(GG1-2)与高级别(GG3-5)前列腺癌。
- 使用FD分析前需将肿瘤信号强度以闭孔内肌为参考进行标准化,以减少扫描仪间差异。
- FD测量操作者依赖性低,适合在临床常规多扫描仪环境下推广应用。
局限性
- ISUP-GG1级仅2例,样本分布极度不均衡,可能影响分级相关性和阈值验证的稳健性。
- 回顾性设计,FD从病灶边缘计算,存在选择偏倚可能。
- 研究未提供不同脂肪饱和方案的具体分类及各方案间的独立验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate fractal dimension (FD) as a quantitative biomarker of prostate cancer (PCa) for the International Society of Urological Pathology Grade Group (ISUP-GG) and validate its diagnostic accuracy using clinical data from multi-scanner sources.
METHODS: Over a 20-month period, 153 men with biopsy-proven PCa aged 48.6-83 years (mean 67.0 ± 7.1 years; ISUP-GG 1-5 distribution: n = 2, 68, 44, 21, and 18), imaged on multiple scanners with differing fat-saturation protocols, had FD retrospectively calculated from the edge of the index lesion. Signal intensities (SI) on dynamic contrast-enhanced magnetic resonance images (DCE-MRI) were normalized to the obturator internus muscle. For reproducibility, 20 patients had repeat FD extracted by an independent observer. FD was correlated with ISUP-GG. Previously determined thresholds were applied to determine diagnostic accuracy of FD for separating ISUP-GGs.
RESULTS: After image normalization, tumor SI values showed similar distributions between scanners. There was a significant correlation between FD and ISUP-GG (R = 0.87, P < .000001). FD was 2.17 ± 0.01 in ISUP-GG1, 2.26 ± 0.04 in ISUP-GG2, 2.34 ± 0.04 in ISUP-GG3, 2.41 ± 0.03 in ISUP-GG4, and 2.42 ± 0.04 in ISUP-GG5. In 20 randomly selected cases, mean inter-reader FD difference was -0.01, Bland-Altman limits of agreement -0.08 to +0.05. A pre-specified threshold from previous datasets of 2.31 separated ISUP-GG1-2 from 3 to 5 with 95.2% sensitivity, 92.9% specificity, and 94.1% diagnostic accuracy.
CONCLUSIONS: FD is an accurate biomarker for grading PCa using standard clinical DCE-MRI with differing fat-saturation schemes that affect SI.
ADVANCES IN KNOWLEDGE: Fractal dimension of DCE-MRI allows for non-invasive stratification of PCa and generalizes to different MRI scanners and fat-saturation protocols.
引用
- Michallek, Gordon, Doran, et al. Validation and diagnostic accuracy of fractal dimension as a biomarker for grading prostate cancer using data from clinical routine. Br J Radiol. 2026. PMID: 42565553. doi:10.1093/bjr/tqag180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。